|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-3-29
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Collateral flow augmentation using partial aortic occlusion may improve cerebral perfusion in acute stroke. We assessed the safety and feasibility of partial aortic occlusion immediately after intravenous tissue plasminogen activator.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1524-4628
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
42
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1135-7
|
|
pubmed:meshHeading |
pubmed-meshheading:21350210-Adult,
pubmed-meshheading:21350210-Aged,
pubmed-meshheading:21350210-Aged, 80 and over,
pubmed-meshheading:21350210-Aorta, Abdominal,
pubmed-meshheading:21350210-Balloon Occlusion,
pubmed-meshheading:21350210-Cerebrovascular Circulation,
pubmed-meshheading:21350210-Combined Modality Therapy,
pubmed-meshheading:21350210-Female,
pubmed-meshheading:21350210-Fibrinolytic Agents,
pubmed-meshheading:21350210-Humans,
pubmed-meshheading:21350210-Hypoxia-Ischemia, Brain,
pubmed-meshheading:21350210-Infusions, Intravenous,
pubmed-meshheading:21350210-Male,
pubmed-meshheading:21350210-Middle Aged,
pubmed-meshheading:21350210-Pilot Projects,
pubmed-meshheading:21350210-Thrombolytic Therapy,
pubmed-meshheading:21350210-Tissue Plasminogen Activator
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Safety and feasibility of collateral blood flow augmentation after intravenous thrombolysis.
|
|
pubmed:affiliation |
Department of Radiology, University of Alberta, Edmonton, Alberta, Canada.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
